Tenaxis Medical said it brought in close to $1.4 million in a still-open funding round.
The Mountain View, Calif.-based medical device company develops and commercializes surgical sealants for vascular and general procedures.
Tenaxis’ marquee product, the ArterX sealant for vascular procedures, uses a prophylactic agent that binds to proteins in both the sealant and the tissue to cross-link them. The sealant has won approval in the U.S. and Europe, according to the Tenaxis website.
The debts-and-warrants round already involves some 30 unnamed investors, according to a regulatory filing. Tenaxis is hoping to raise total of $1.5 million, according to the filing.
